Protanopia

Protanopia is a form of color vision deficiency in which the long-wavelength sensitive cones (often called “red” cones) are either absent or nonfunctional. People with protanopia perceive reds, oranges, and yellows very differently from those with normal color vision. Specifically, reds often appear darker, and certain shades of green and brown can look identical to shades of gray or black. This condition is congenital in the vast majority of cases, meaning individuals are born with it, although rarely it can arise later in life due to eye disease or injury.

At the cellular level, normal color vision relies on three types of cone photoreceptors in the retina: short-wavelength (S), medium-wavelength (M), and long-wavelength (L) cones. In protanopia, mutations in the gene that encodes the L-cone photopigment lead to its complete absence. As a result, the visual system only receives signals from the S and M cones, effectively reducing color perception to two channels. This leads to confusion primarily between reds and greens, a hallmark of red–green color blindness.

The hereditary pattern of protanopia is X-linked recessive. Since the gene for the L-cone opsin is located on the X chromosome, males (with one X chromosome) are affected if that single X carries the mutation, while females (with two X chromosomes) are typically carriers unless both X chromosomes carry the mutation. Consequently, approximately 1% of males worldwide have protanopia, whereas it is exceedingly rare in females.

Beyond the genetic basis, the way protanopia manifests in daily life can vary. Some individuals may not be aware of their condition until they face tasks that rely on red–green discrimination, such as interpreting colored charts, traffic lights, maps, or identifying ripe fruits. Others discover it during routine vision screenings in school or at work. Although protanopia cannot be “cured,” various tools—like specially tinted glasses, digital filters, or adaptive smartphone apps—can improve color discrimination by enhancing contrast between problematic hues.

Understanding protanopia is important not only for individuals and their families but also for designers, educators, and employers who need to ensure that information conveyed by color is accessible to those with color vision deficiencies. By choosing color palettes with sufficient contrast and alternative indicators (patterns, labels, shapes), environments and materials can be made inclusive to people with protanopia.

Types of Protanopia

Congenital Protanopia. Congenital protanopia is present from birth due to inherited mutations affecting the L-cone photopigment gene (OPN1LW). Individuals never develop functional red cones, and their color perception remains unchanged throughout life. Because it is genetic, family history often reveals other male relatives with similar red–green color confusion. Genetic counseling can help families understand inheritance patterns and carrier risks.

Acquired Protanopia. Although rare, protanopic-like symptoms can develop later in life due to ocular or neurological diseases. Conditions such as diabetic retinopathy, age-related macular degeneration, glaucoma, optic neuritis, or traumatic injury to the retina or optic nerve can selectively damage L-cones or their neural pathways. In these cases, a person’s color vision may gradually worsen with disease progression. Unlike congenital protanopia, acquired forms may sometimes be partially reversible if underlying disease is treated early.

Causes of Protanopia

1. OPN1LW Gene Mutations. The most common cause of congenital protanopia is a mutation in the OPN1LW gene on the X chromosome. This gene encodes the photopigment in L-cones. When mutated, the photopigment is either not produced or is nonfunctional, leading to absence of red cone responses.

2. X-Linked Recessive Inheritance. Because the gene resides on the X chromosome, males with a single mutated copy are affected, whereas females require mutations on both X chromosomes to manifest protanopia. Female carriers often have normal color vision but can pass the mutation to children.

3. Gene Deletion. In some families, large deletions remove the entire OPN1LW gene, resulting in no production of the L-cone pigment. Such deletions typically produce a classic, complete protanopia phenotype.

4. Opsin Gene Hybridization. Unequal recombination between the OPN1LW (red) and OPN1MW (green) genes can create hybrid photopigment genes that do not function properly, leading to a protanopic phenotype if the hybrid lacks L-cone function.

5. Genetic Mosaicism. Rarely, mosaicism (where only a subset of cells carry the mutation) can cause a partial or variable protanopia. Patients may have some functioning L-cones mixed with nonfunctional ones, leading to milder symptoms.

6. Consanguinity. In communities with high rates of consanguineous marriages, the frequency of X-linked mutations can increase, slightly raising protanopia prevalence among males.

7. Diabetic Retinopathy. Chronic high blood sugar in diabetes damages retinal blood vessels, which can damage L-cones and mimic acquired protanopia symptoms.

8. Age-Related Macular Degeneration. As the macula degenerates with age, photoreceptor cells—including L-cones—deteriorate, causing acquired red–green color confusion.

9. Glaucoma. Elevated intraocular pressure damages retinal ganglion cells and can interfere with the signals from L-cones, leading to acquired protanopic changes.

10. Optic Neuritis. Inflammation of the optic nerve in conditions like multiple sclerosis can disrupt transmission of L-cone signals, causing temporary or permanent protanopic-like deficits.

11. Retinitis Pigmentosa. Although primarily affecting rods, some forms also involve cone degeneration. If L-cones are preferentially lost, protanopia can develop.

12. Ocular Trauma. Direct injury to the retina or choroid (from blunt or penetrating trauma) can destroy L-cones and produce an acquired protanopia.

13. Hydroxychloroquine Toxicity. Long-term use of certain drugs (like hydroxychloroquine) can selectively damage photoreceptors, sometimes leading to acquired red–green color vision loss.

14. Chemical Exposure. Industrial chemicals such as carbon disulfide or styrene can impair cone function when inhaled chronically, occasionally leading to protanopic symptoms.

15. Neurological Lesions. Lesions in the visual cortex (particularly in area V4, which processes color) can mimic protanopia by preventing the brain from interpreting L-cone signals correctly, even if the retina is intact.

Common Symptoms of Protanopia

1. Red–Green Confusion. The hallmark symptom is difficulty distinguishing between reds and greens. For example, a red apple may appear dark brown or black, and grass may appear beige or cream-colored.

2. Darkened Reds. Reds often appear darker than they actually are. A bright red light might look like dim amber, making traffic signals particularly challenging.

3. Difficulty with Color-Coded Information. Charts, graphs, or maps that use red and green can be unreadable without alternative indicators like patterns or labels.

4. Trouble with Colored Lights. Identifying brake lights, traffic lights, or colored warning indicators on machinery can be hazardous, especially in dim lighting.

5. Educational Challenges. Children with protanopia may struggle in school when tasks involve colors—such as art projects, science diagrams, or colored worksheets—leading to frustration.

6. Social Misunderstandings. Mistaking color-dependent cues (e.g., ripe fruits, fashion choices, holiday decorations) can cause embarrassment or social anxiety.

7. Eye Strain and Fatigue. Frequent guessing or rechecking color-coded tasks can lead to visual fatigue and headaches after prolonged work.

8. Limited Career Options. Professions requiring accurate color discrimination—such as electrical work, piloting, or graphic design—may be difficult or inaccessible without adaptive tools.

9. Dependence on Memory and Context. People with protanopia often learn to rely on object shape, position, or lighting context instead of color to identify items (such as knowing that the top traffic light is red even if they cannot see the color).

10. Safety Concerns. Misinterpreting colored warning labels (e.g., on chemicals or electrical equipment) can pose safety risks in laboratories or industrial settings.

Diagnostic Tests for Protanopia

Physical Exam

1. Visual Acuity Assessment. Measures clarity of vision using a Snellen chart. Although protanopia does not affect sharpness, this exam rules out other vision impairments before specialized color testing.

2. Pupillary Light Reflex. Observes how pupils constrict in response to bright light. An abnormal reflex can indicate optic nerve or retinal disease, which might underlie acquired protanopia.

3. Slit‑Lamp Examination. Uses a microscope with a bright light to inspect the cornea, lens, and anterior retina. Ensures no structural eye disease is causing color vision changes.

Manual Color Vision Tests

4. Ishihara Pseudoisochromatic Plates. The most widely used screening tool, consisting of colored dot patterns that form numbers. Individuals with protanopia fail to see certain numerals embedded in red–green plates.

5. Farnsworth–D15 Test. Involves arranging colored caps in sequence based on hue. Protanopes make characteristic crossing errors, especially between red and green sectors.

6. Hardy–Rand–Rittler (HRR) Plates. Similar to Ishihara but includes grading severity and testing for blue–yellow deficiencies, offering a more nuanced color vision profile.

7. Nagel Anomaloscope. A precision instrument that displays a bipartite field of red and green lights. The subject adjusts a mixture to match a yellow reference; protanopes cannot match typical ratios.

8. City University Color Vision Test. Features small colored discs that the examinee must match to a set of samples; sensitive for detecting subtle red–green defects.

9. Cambridge Colour Test. Computer-based test that systematically varies color and luminance; quantifies the exact threshold at which color confusion occurs.

10. Lantern Tests (e.g., Farnsworth Lantern). Simulate real-world signals (e.g., ship navigation lights) where the patient identifies colored lights at various intensities.

Lab and Pathological Tests

11. Genetic Sequencing for OPN1LW. DNA analysis from a blood sample or cheek swab identifies specific mutations or deletions in the L-cone opsin gene, confirming congenital protanopia.

12. Prenatal Genetic Diagnosis. In families with known gene mutations, amniocentesis or chorionic villus sampling can detect OPN1LW mutations before birth.

13. Retinal Histopathology. Rarely performed in research settings, involves microscopic examination of retinal tissue (e.g., postmortem) to confirm absence of L-cones.

Electrodiagnostic Tests

14. Full‑Field Electroretinogram (ERG). Records electrical responses of all retinal photoreceptors to light flashes. In protanopia, photopic (light-adapted) responses show reduced or absent L-cone contributions.

15. Photopic Single‑Flash ERG. Uses selective wavelengths to isolate cone responses under bright light; protanopes have abnormal or flat waves at red wavelengths.

16. Flicker ERG. Measures cone function at high flicker rates; changes in amplitude or timing at long wavelengths indicate L-cone dysfunction.

17. Visual Evoked Potentials (VEP). Electrodes on the scalp record cortical responses to color-specific stimuli; protanopes show reduced cortical activity in response to red stimuli.

Imaging Tests

18. Optical Coherence Tomography (OCT). High-resolution cross-sectional images of the retina reveal structural integrity of the photoreceptor layer, ensuring cones are present but may be nonfunctional.

19. Fundus Photography. Captures detailed images of the retina; used primarily to rule out retinal diseases that could cause acquired color vision changes.

20. Fundus Autofluorescence. Imaging that highlights metabolic activity in retinal pigment epithelium; helps detect early retinal degeneration that might impair cone function.

Non‑Pharmacological Treatments

Non‑drug therapies form the cornerstone of living well with protanopia. They fall into three broad categories—exercise therapies, mind‑body approaches, and educational self‑management—each designed to strengthen compensatory skills, enhance color recognition strategies, and build confidence.

Exercise Therapies

1. Color‑Association Drills

   • Description: Repetitive matching exercises using colored cards or digital apps.

   • Purpose: To reinforce memory of object–color relationships (e.g., “strawberries are red”) so that learned associations compensate for perceptual ambiguity.

   • Mechanism: By repeatedly pairing a known object with its typical color, the brain learns to infer color identity via context rather than cone input.

2. Contrast Sensitivity Training

   • Description: Tasks that boost ability to detect differences in brightness and contrast, such as shading puzzles.

   • Purpose: To sharpen non‑color visual cues, making shapes and edges more distinct.

   • Mechanism: Increases reliance on luminance rather than chromatic cues, enhancing overall visual discrimination.

3. Adaptive Lighting Exercises

   • Description: Practicing under varied light sources (e.g., incandescent vs. LED) to learn which settings optimize object recognition.

   • Purpose: To identify lighting conditions that maximize color contrast for the individual.

   • Mechanism: Adjusting to spectral power distributions that heighten the remaining cone responses.

4. Digital Simulation Exposure

   • Description: Using software that simulates typical color‑vision environments (e.g., traffic lights, color-coded maps).

   • Purpose: To habituate recognition of critical signals in a safe, controlled way.

   • Mechanism: Repeated exposure strengthens recognition pathways via neuroplasticity.

5. Peripheral Cue Training

   • Description: Exercises focusing on peripheral vision tasks (e.g., identifying shapes at the edge of the visual field).

   • Purpose: To develop broader visual strategies that supplement central color discrimination.

   • Mechanism: Engages rods and M‑cones more effectively, improving overall scene interpretation.

Mind‑Body Approaches

6. Mindful Visual Awareness

   • Description: Meditation practices that cultivate non‑judgmental attention to visual experiences.

   • Purpose: To reduce frustration and anxiety when colors appear confusing.

   • Mechanism: Lowers limbic‑system stress responses, improving cognitive flexibility and adaptation.

7. Stress‑Reduction Techniques

   • Description: Progressive muscle relaxation or guided imagery focused on vision tasks.

   • Purpose: To decrease tension that might exacerbate perceptual errors under pressure (e.g., driving).

   • Mechanism: Reduces cortisol levels, enhancing attentional control and reducing visual fatigue.

8. Cognitive Reframing

   • Description: Therapy that reinterprets color‑vision deficiency as a unique trait rather than a deficit.

   • Purpose: To build self‑esteem and resilience against social stigma.

   • Mechanism: Alters maladaptive thought patterns, improving mood and visual performance.

9. Visualization Techniques

   • Description: Mentally rehearsing tasks with correct color identification (e.g., imagining a green traffic light).

   • Purpose: To prime neural circuits for accurate decision‑making.

   • Mechanism: Strengthens synaptic connections through mental practice, akin to physical rehearsal.

10. Biofeedback for Eye‑Strain

    • Description: Monitoring muscle tension around the eyes while performing color tasks.

    • Purpose: To become aware of and reduce unconscious squinting or tensing that worsens vision.

    • Mechanism: Teaches voluntary control of oculomotor muscles, decreasing visual fatigue.

Educational Self‑Management

11. Color‑Coding Systems

    • Description: Labeling objects with symbols or textures (e.g., raised dots on clothing tags).

    • Purpose: To provide reliable, non‑color cues for daily tasks.

    • Mechanism: Substitutes tactile or shape information for chromatic discrimination.

12. Assistive Smartphone Apps

    • Description: Apps that identify and name colors via camera input.

    • Purpose: To offer real‑time auditory or textual feedback.

    • Mechanism: Uses digital image processing and text‑to‑speech to bypass deficient cones.

13. Personalized Color Palettes

    • Description: Curating clothing or home decor around a limited, high‑contrast palette.

    • Purpose: To minimize confusion and simplify color choices.

    • Mechanism: Relies on stark luminance differences instead of hue.

14. Visual Strategy Workshops

    • Description: Group sessions teaching practical tips (e.g., using position of traffic lights instead of color).

    • Purpose: To share peer‑tested coping strategies.

    • Mechanism: Social learning amplifies adoption of effective techniques.

15. Environmental Adaptation Guides

    • Description: Manuals showing how to adjust workspaces (e.g., high‑contrast charts for presentations).

    • Purpose: To optimize professional performance.

    • Mechanism: Applies universal design principles, enhancing accessibility.

16. Routine Vision Screenings

    • Description: Scheduled self‑tests using Ishihara or Farnsworth D‑15 plates.

    • Purpose: To monitor any changes or co‑existing vision issues.

    • Mechanism: Early detection of other ocular conditions ensures timely care.

17. Color‑Vision ID Cards

    • Description: Carrying a card that explains one’s color‑vision status to others.

    • Purpose: To facilitate accommodations in social or workplace settings.

    • Mechanism: Acknowledges disability, prompting constructive support.

18. Living Skills Training

    • Description: Occupational‑therapy sessions focused on meal prep, sewing, or gardening with color challenges.

    • Purpose: To practice real‑world tasks safely.

    • Mechanism: Builds procedural memory to replace unreliable color cues.

19. Online Support Communities

    • Description: Forums or social‑media groups for color‑blind individuals.

    • Purpose: To exchange tips, emotional support, and new tech discoveries.

    • Mechanism: Peer validation reduces isolation, fosters adaptive innovation.

20. Customized Educational Materials

    • Description: Textbooks or slides with annotations indicating color choices (e.g., “the red area here appears dark gray to me”).

    • Purpose: To level the academic playing field.

    • Mechanism: Instructor‑provided guidance replaces ambiguous chromatic information.

---

Pharmacological Treatments

Note: Protanopia is a genetic absence of L‑opsin cones. Currently, there are no FDA‑approved drugs that restore color vision. Management relies on non‑drug strategies and emerging biotechnologies rather than traditional pharmacotherapy.

---

Dietary Molecular Supplements

While no vitamin or supplement cures protanopia, certain nutrients support overall retinal health and may optimize residual cone function:

1. Lutein (10 mg/day)

   • Function: Filters blue light and supports macular pigments.

   • Mechanism: Accumulates in the retina, protecting photoreceptors from oxidative stress.

2. Zeaxanthin (2 mg/day)

   • Function: Complements lutein in macular pigment density.

   • Mechanism: Shields cone cells and enhances visual acuity under bright light.

3. Omega‑3 Fatty Acids (DHA/EPA, 1 g/day)

   • Function: Maintains photoreceptor membrane fluidity.

   • Mechanism: Integrates into retinal cell membranes, promoting signal transduction.

4. Vitamin A (Retinol, 5,000 IU/day)

   • Function: Precursor for retinal chromophore (11‑cis‑retinal).

   • Mechanism: Ensures adequate rhodopsin synthesis, indirectly supporting cone‑rod coupling.

5. Vitamin C (500 mg twice daily)

   • Function: Antioxidant protecting ocular tissues.

   • Mechanism: Neutralizes free radicals in the vitreous and retina.

6. Vitamin E (400 IU/day)

   • Function: Lipid‑soluble antioxidant for photoreceptor membranes.

   • Mechanism: Prevents peroxidative damage to cone outer segments.

7. Zinc (40 mg/day)

   • Function: Cofactor in visual pigment formation.

   • Mechanism: Stabilizes cell membranes and facilitates vitamin A metabolism.

8. Copper (2 mg/day)

   • Function: Works with zinc in retinal antioxidant enzymes.

   • Mechanism: Helps superoxide dismutase activity, protecting photoreceptors.

9. Bilberry Extract (160 mg twice daily)

   • Function: Anthocyanins that may improve microcirculation.

   • Mechanism: Enhances retinal blood flow, promoting nutrient delivery.

10. Citicoline (1 g/day)

    • Function: Neuroprotective for retinal ganglion cells.

    • Mechanism: Supplies intermediates for phospholipid synthesis, supporting synaptic health.

---

Regenerative & Stem‑Cell Therapies (Investigational)

Six cutting‑edge approaches aim to address the root genetic cause of protanopia:

1. AAV‑Mediated L‑Opsin Gene Replacement

   • Dosage: Subretinal injection of 1 × 10¹¹ vector genomes per eye.

   • Function: Delivers a functional OPN1LW gene to dormant cones.

   • Mechanism: AAV2 vector transduces retinal cells, restoring L‑opsin production.

2. CRISPR/Cas9‑Based Gene Editing

   • Dosage: Intravitreal delivery of CRISPR ribonucleoprotein complexes.

   • Function: Corrects point mutations in the OPN1LW gene.

   • Mechanism: Guide RNA targets mutant allele; Cas9 nuclease excises defect, enabling endogenous repair.

3. iPSC‑Derived Photoreceptor Transplants

   • Dosage: Injection of ~500,000 photoreceptor precursor cells.

   • Function: Replaces absent L‑cones with engineered cells.

   • Mechanism: Stem cells differentiate into L‑cone–like cells, integrating into outer retina.

4. Mesenchymal Stem Cell (MSC) Therapy

   • Dosage: Intravitreal injection of 1–2 × 10⁶ MSCs.

   • Function: Provides neurotrophic support to surviving cones.

   • Mechanism: MSCs secrete growth factors (e.g., BDNF), promoting cell survival.

5. Optogenetic Sensitization

   • Dosage: Subretinal AAV-opsin vector (similar titer to gene replacement).

   • Function: Makes non‑photoreceptive cells (e.g., bipolar) light‑sensitive.

   • Mechanism: Channelrhodopsin expression enables these cells to respond to red wavelengths.

6. Neuroprotective Small‑Molecule Delivery

   • Dosage: Intravitreal depot of CNTF analogues.

   • Function: Slows degeneration of cone precursors.

   • Mechanism: CNTF receptor activation boosts survival pathways in retinal neurons.

Status: All above remain in Phase I/II trials. No approval yet.

---

Surgical & Device‑Based Interventions

Five procedures aim to improve functional vision by delivering therapies or prosthetics:

1. Subretinal Vector Injection

   • Procedure: Microsurgical detachment of retina, infusion of viral vector.

   • Benefits: Direct gene delivery to target photoreceptors, high transduction efficiency.

2. Intravitreal Injection

   • Procedure: Needle injection of vector/drug into vitreous cavity.

   • Benefits: Less invasive, outpatient procedure, wide retinal distribution.

3. Retinal Prosthesis Implantation

   • Procedure: Surgical placement of electrode array on epiretinal surface.

   • Benefits: Bypasses photoreceptors entirely, converting light into electrical signals.

4. Optogenetic Prosthesis

   • Procedure: Combines vector injection with subretinal microLED implant.

   • Benefits: Enables precise stimulation of optogenetically sensitized cells.

5. Photoreceptor Precursor Transplantation

   • Procedure: Delivery of stem‑cell–derived precursors into outer retinal layer.

   • Benefits: Potential for long‑term cell integration and true photoreceptor replacement.

---

Prevention Strategies

Because protanopia is hereditary, primary prevention focuses on reproductive counseling and awareness:

1. Carrier Genetic Testing before family planning

2. Preimplantation Genetic Diagnosis with IVF

3. Prenatal Genetic Counseling for at‑risk couples

4. Avoidance of Ototoxic/Teratogenic Agents during pregnancy

5. Public Education on color‑vision inheritance patterns

6. Newborn Vision Screening for early detection

7. Workplace Awareness Programs to accommodate color‑deficient employees

8. Designing Color‑Blind–Friendly Environments (e.g., dual coding)

9. Promoting Universal Design in education and transport

10. Development of Assistive Technologies via policy incentives

---

When to See a Doctor

• At Birth/Infancy: If routine screening suggests color‑vision issues.

• Before Starting School: To arrange educational accommodations.

• Adolescence/Work Entry: For career guidance in color‑critical fields.

• With Sudden Vision Changes: To rule out acquired color‑vision loss from eye disease.

• When Gene‑Therapy Trials Open: To determine eligibility.

---

“Do’s” and “Don’ts”

1. Do use position cues (e.g., remembering traffic‑light order).

2. Don’t rely on color alone for safety signals.

3. Do label household items with symbols or text.

4. Don’t assume everyone sees colors the same way.

5. Do choose high‑contrast color combinations in documents.

6. Don’t purchase “color correction” pills—none are proven.

7. Do explore apps and filters that name or enhance colors.

8. Don’t ignore regular eye exams—other issues can co‑exist.

9. Do inform friends, family, and employers about your condition.

10. Don’t let misconceptions hold you back—adapt with strategies.

---

Frequently Asked Questions

1. Can protanopia be cured?
   Currently, there’s no cure, but experimental gene and stem‑cell therapies offer hope in clinical trials.

2. Will tinted glasses help?
   Specialized lenses (e.g., EnChroma®) can enhance contrast between reds and greens, improving discrimination for some individuals.

3. Can I become a pilot?
   Commercial airlines generally require normal color vision; some military or private licenses may allow exceptions with simulations.

4. Is protanopia the same as red‑green color blindness?
   It’s one subtype of red‑green deficiencies, specifically lacking L‑cones (protan), whereas deuteranopia lacks M‑cones.

5. How is it diagnosed?
   Through Ishihara plates, anomaloscope testing, or arrangement tests like Farnsworth D‑15.

6. Does it worsen with age?
   No—it’s nonprogressive, though you should monitor for other age‑related eye diseases.

7. Are females affected?
   Yes, but far less commonly (around 1%) because two X‑chromosomes are required to inherit the trait.

8. Can color vision change after injury?
   Acquired color deficiencies can occur post‑trauma, but congenital protanopia remains stable.

9. Should children be tested early?
   Yes—early identification allows tailored learning tools and safety planning.

10. Do vitamins help restore color vision?
    No specific vitamin restores missing cones, though supplements support overall eye health.

11. Is driving safe?
    With awareness of signal positions and compensatory strategies, many drive safely—check local regulations.

12. Can technology fully replace color vision?
    Apps and filters help, but none perfectly replicate normal trichromatic vision.

13. Are there support groups?
    Yes—online forums (e.g., Colour Blind Awareness) and local vision‑disability networks provide resources.

14. What careers are best?
    Jobs without critical color tasks—IT, writing, engineering, many non‑laboratory sciences.

15. Where can I find trials?
    ClinicalTrials.gov lists recruiting gene‑therapy studies for inherited retinal disorders; discuss options with a retinal specialist.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 19, 2025.